Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| OLEMA PHARMACEUTICALS | 5 | - | 0,00 % | ||
| CYTOMX THERAPEUTICS | 4 | 2 | +58,72 % | ||
| ZENAS BIOPHARMA | 4 | - | 0,00 % | ||
| BIONTECH | 3 | 13 | +1,19 % | ||
| INCYTE | 2 | 25 | 0,00 % | ||
| MONTE ROSA THERAPEUTICS | 2 | 21 | 0,00 % | ||
| SUMMIT THERAPEUTICS | 2 | 12 | 0,00 % | ||
| BEONE MEDICINES LTD ADR | 2 | 10 | +1,60 % | ||
| ALNYLAM PHARMACEUTICALS | 2 | 9 | -0,15 % | ||
| LYELL IMMUNOPHARMA | 2 | 8 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:18 | Mirum completes enrollment in cholestatic pruritus trial | - | Investing.com | ||
| 13:12 | Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M | 4 | Seeking Alpha | ||
| 13:08 | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
| 13:01 | Structure Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12:54 | Wedbush lowers Xenon Pharmaceuticals stock price target to $63 | 1 | Investing.com | ||
| 12:54 | H.C. Wainwright reiterates Sana Biotechnology stock buy rating | 2 | Investing.com | ||
| 12:48 | Olema Pharmaceuticals GAAP EPS of -$0.50 beats by $0.01 | 1 | Seeking Alpha | ||
| 12:47 | Zenas BioPharma, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 12:42 | Zenas BioPharma, Inc. GAAP EPS of -$4.54 misses by $3.66 | 1 | Seeking Alpha | ||
| 12:39 | BioNTech a Takeover Target? What's Happening at CHAR Technologies and Steyr Motors? | 15 | The Market Herald Canada | ||
| 12:38 | GH Research PLC - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12:36 | Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million | 38 | GlobeNewswire (Europe) | BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare... ► Artikel lesen | |
| 12:34 | BTIG startet Coverage für Zevra Therapeutics mit Kaufempfehlung wegen Miplyffa-Ausblick | 1 | Investing.com Deutsch | ||
| 12:30 | Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report | 3 | Benzinga.com | ||
| 12:30 | Monte Rosa rises on J&J collaboration for cancer therapy trial | 5 | Seeking Alpha | ||
| 12:27 | Zenas BioPharma, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12:19 | Olema Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 12:17 | Zenas BioPharma, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12:12 | CytomX Therapeutics Inc.: CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update | 43 | GlobeNewswire (Europe) | - Announced Positive Data from Phase 1 Dose Expansion Study of varsetatug masetecan ("Varseta-M") EpCAM PROBODY ADC in Patients with Advanced Colorectal Cancer (CRC) - - FDA interactions targeted... ► Artikel lesen | |
| 12:12 | CytomX GAAP EPS of -$0.15 misses by $0.12, revenue of $76.2M misses by $6.69M | 4 | Seeking Alpha |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.